Don't Just Read the News, Understand It.

Published 3 years ago • loading... • Updated 3 years ago

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Summary by Ground News

ProPhase Labs, Inc. (PRPH) is one of 1184 individual stocks in the Medical sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Consensus Estimate for PRPH's full-year earnings has moved 107.6% higher within the past quarter.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Zacks Investment Research

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Here is how ProPhase Labs, Inc. (PRPH) and RVL Pharmaceuticals PLC (RVLP) have performed compared to their sector so far this year.

3 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated3 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Zacks Investment Research broke the news in 3 years ago on Thursday, May 26, 2022.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.